Global Medical REIT Announces Second Quarter 2025 Financial Results

Did the REIT announce any new acquisitions or disposals during the quarter? How did occupancy levels change during the quarter and what is the current portfolio occupancy? How did the REIT’s credit rating change, if at all, following the release? What was the revenue growth rate versus the prior quarter and year‑over‑year? Are there any regulatory or policy changes on the horizon that could affect the REIT’s operations or valuation? How does the REIT’s valuation multiples (FFO P/E, EV/EBITDA) compare to its main competitors? What is the REIT’s current debt‑to‑equity ratio and any recent changes in leverage? What capital expenditures (CapEx) were undertaken, and how do they impact the balance sheet and cash flow? How does the current dividend yield compare to other medical REITs and to the REIT’s own historical yield? Did the REIT provide any guidance for Q3 2025 or full‑year 2025, and how does it align with market expectations? What impact, if any, did macro‑economic factors (interest rates, healthcare demand) have on the results? Are there any significant lease expirations or renewal activity that could affect future cash flows? What is the outlook for rental growth in the medical office sector and how might it affect the REIT’s future performance? What are the key drivers behind any change in net operating income (NOI) this quarter? How does the reported earnings per share compare to analyst consensus estimates for Q2 2025?